Diabetes, lower extremity amputation, loss of protective sensation, and neuronal nitric oxide synthase associated protein in the chronic renal insufficiency cohort study

Wound Repair and Regeneration

Volumn 21, Issue 1, 2013, Pages 17-24

  Margolis, David J ^a   Gupta, Jayanta ^a   Thom, Stephen R ^a   Townsend, Raymond R ^b   Kanetsky, Peter A ^a   Hoffstad, Ole ^a   Papdopoulos, Maryte ^a   Fischer, Michael ^c,d   Schelling, Jeffrey R ^e   Mitra, Nandita ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; NEURONAL NITRIC OXIDE SYNTHASE;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; FEMALE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LEG AMPUTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RACE DIFFERENCE; SENSATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AFRICAN AMERICANS; AGED; AMPUTATION; COHORT STUDIES; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LOWER EXTREMITY; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; UNITED STATES;

EID: 84872112419     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00866.x     Document Type: Article

References (43)

1. Margolis D, Malay DS, Hoffstad OJ, Leonard CE, MaCurdy T, Lopez de Nava K, Tan Y, Molina T, Siegel KL,. Economic burden of diabetic foot ulcers and amputations among Medicare beneficiaries, 2006 to 2008. Rockville, MD: Agency for Healthcare Research and Quality, 2010.
2. Margolis DJ, Hoffstad O, Nafash J, Leonard CE, Freeman CP, Hennessy S, Wiebe DJ,. Location, location, location: geographic clustering of lower-extremity amputation among Medicare beneficiaries with diabetes. Diabetes Care 2011; 34: 2363-2367.
3. Malay DS, Margolis DJ, Hofstad O, Bellamy S,. The incidence and risks of failure to heal following lower extremity amputation for the treatment of diabetic neuropathic foot ulcer. J Foot Ankle Surg 2006; 45: 366-375.
4. Boulton AJ, Kirsner RS, Vileikyte L,. Clinical practice. Neuropathic diabetic foot ulcers. N Engl J Med 2004; 351: 48-55.
5. Reiber GE, Vileikyte L, Boyko EJ, del, Aguila M, Smith DG, Lavery LA, Boulton AJ,. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999; 22: 157-162.
6. Edwards JL, Vincent AM, Cheng HT, Feldman EL,. Diabetic neuropathy: mechanisms to management. Pharmacol Ther 2008; 120: 1-34.
7. Boulton AJ,. Diabetic neuropathy: classification, measurement and treatment. Curr Opin Endocrinol Diabetes Obes 2007; 14: 141-145.
8. da Silva L, Carvalho E, Cruz MT,. Role of neuropeptides in skin inflammation and its involvment in diabetic wound healing. Expert Opin Biol Ther 2010; 10: 1427-1439.
9. Kone BC, Kuncewicz T, Zhang W, Yu Z,. Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric axide. Am J Physiol Renal Physiol 2003; 285: F178-F190.
10. Lu J, Hu C, Hu W, Zhang R, Wang C, Qin W, Yu W, Xiang K,. A common variant of NOS1AP is associated with QT interval duration in a Chinese population with Type 2 diabetes. Diabet Med 2010; 27: 1074-1079.
11. Hadzimichalis NM, Previtera ML, Moreau MP, Li B, Lee GH, Dulencin AM, Matteson PG, Buyske S, Millonig JH, Brzustowicz LM, Firestein BL,. NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia. Schizophr Res 2010; 124: 248-250.
12. Carrel D, Du Y, Komlos D, Hadzimichalis NM, Kwon M, Wang B, Brzustowicz LM, Firestein BL,. NOS1AP regulates dendrite patterning of hippocampal neurons through a carboxypeptidase E-mediated pathway. J Neurosci 2009; 29: 8248-8258.
13. Crotti L, Monti MC, Insolia R, Peljto A, Goosen A, Brink PA, Greenberg DA, Schwartz PJ, George AL Jr,. NOS1AP is a genetic modifier of the long-QT syndrome. Circulation 2009; 120: 1657-1663.
14. Kao WH, Arking DE, Post W, Rea TD, Sotoodehnia N, Prineas RJ, Bishe B, Doan BQ, Boerwinkle E, Psaty BM, Tomaselli GF, Coresh J, Siscovick DS, Marban E, Spooner PM, Burke GL, Chakravarti A,. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation 2009; 119: 940-951.
15. Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, Fink JC, Fischer MJ, Gadegbeku C, Hamm LL, Kusek JW, Landis JR, Narva A, Robinson N, Teal V, Feldman HI,; Chronic Renal Insufficiency Cohort (CRIC) Study Group. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol: CJASN 2009; 4: 1302-1311.
16. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT, Galver L, Barrett JC, Grant SF, Farlow DN, Chandrupatla HR, Hansen M, Ajmal S, Papanicolaou GJ, Guo Y, Li M, Derohannessian S, de, Bakker PI, Bailey SD, Montpetit A, Edmondson AC, Taylor K, Gai X, Wang SS, Fornage M, Shaikh T, Groop L, Boehnke M, Hall AS, Hattersley AT, Frackelton E, Patterson N, Chiang CW, Kim CE, Fabsitz RR, Ouwehand W, Price AL, Munroe P, Caulfield M, Drake T, Boerwinkle E, Reich D, Whitehead AS, Cappola TP, Samani NJ, Lusis AJ, Schadt E, Wilson JG, Koenig W, McCarthy MI, Kathiresan S, Gabriel SB, Hakonarson H, Anand SS, Reilly M, Engert JC, Nickerson DA, Rader DJ, Hirschhorn JN, Fitzgerald GA,. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS ONE [Electronic Resource] 2008; 3: e3583.
17. Isakova T, Anderson CA, Leonard MB, Xie D, Gutierrez OM, Rosen LK, Theurer J, Bellovich K, Steigerwalt SP, Tang I, Anderson AH, Townsend RR, He J, Feldman HI, Wolf M,; Chronic Renal Insufficiency Cohort (CRIC) Study Group. Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. Nephrol Dial Transplant 2011; 26: 1258-1265.
18. Townsend RR, Anderson AH, Chen J, Gadebegku CA, Feldman HI, Fink JC, Go AS, Joffe M, Nessel LA, Ojo A, Rader DJ, Reilly MP, Teal V, Teff K, Wright JT, Xie D,. Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Nephrol 2011; 33: 477-484.
19. Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED, Go AS, Hamm LL, He J, Hostetter T, Hsu CY, Jamerson K, Joffe M, Kusek JW, Landis JR, Lash JP, Miller ER, Mohler ER, III, Muntner P, Ojo AO, Rahman M, Townsend RR, Wright JT,; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. The chronic renal insufficiency cohort (CRIC) Study: design and methods. J Am Soc Nephrol 2003; 14 (7 Suppl 2): S148-S153.
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
21. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D,. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909.
22. Benjamini Y, Yekutieli D,. The control of the false discovery rate in multiple testing under dependency. Ann Statistics 2001; 29: 1165-1188.
23. Barrett JC, Fry B, Maller J, Daly MJ,. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
24. Lake S, Lyon H, Silverman E, Weiss S, Laird N, Schaid D,. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003; 55: 56-65.
25. Vileikyte L, Rubin RR, Peyrot M, Gonzalez JS, Boulton AJ, Ulbrecht JS, Cavanagh PR,. Diabetic feet. Br J Gen Pract 2009; 59: 290.
26. Boulton AJ, Malik RA,. Neuropathy of impaired glucose tolerance and its measurement. Diabetes Care 2010; 33: 207-209.
27. Bril V, England JD, Franklin GM, Backonja M, Cohen JA, Del Toro DR, Feldman EL, Iverson DJ, Perkins B, Russell JW, Zochodne DW,. Evidence-based guideline: treatment of painful diabetic neuropathy-report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation. Neurology 2011; 77: 1758-1765
28. Boulton AJ, Malik RA,. Diabetic neuropathy. Med Clin North Am 1998; 82: 909-929.
29. Pecoraro RE, Ahroni JH, Boyko EJ, Stensel VL,. Chronology and determinants of tissue repair in diabetic lower-extremity ulcers. Diabetes 1991; 40: 1305-1313.
30. Figueroa-Romero C, Sadidi M, Feldman EL,. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord 2008; 9: 301-314.
31. Russell JW, Berent-Spillson A, Vincent AM, Freimann CL, Sullivan KA, Feldman EL,. Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol Dis 2008; 30: 420-429.
32. Charles M, Ejskjaer N, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbaek A,. Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes. Diabetes Care 2011; 34: 2244-2249.
33. Abbott CA, Chaturvedi N, Malik RA, Salgami, E, Yates AP, Pemberton PW, Boulton AJ,. Explanations for the lower rates of diabetic neuropathy in Indian Asians versus Europeans. Diabetes Care 2010; 33: 1325-1330.
34. Adler AI, Boyko EJ, Ahroni JH, Smith DG,. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 1999; 22: 1029-1035.
35. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG,. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999; 22: 1036-1042.
36. Margolis DJ, Taylor LA, Hofstad O, Berlin JA,. Diabetic neuropathic foot ulcers and amputation. Wound Repair Regen 2005; 113: 230-236.
37. Margolis DJ, Hofstad O, Feldman HI,. Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes. Diabetes Care 2008; 31: 1331-1336.
38. Van Gils CC, Roeder B,. The effect of ankle equinus upon the diabetic foot. [Review] [66 refs]. Clin Podiatr Med Surg 2002; 19: 391-409.
39. Lavery LA, Hunt NA, Ndip A, Lavery DC, Van HW, Boulton AJ,. Impact of chronic kidney disease on survival after amputation in individuals with diabetes. Diabetes Care 2010; 33: 2365-2369.
40. Freeman A, May K, Frescos N, Wraight PR,. Frequency of risk factors for foot ulceration in individuals with chronic kidney disease. Intern Med J 2008; 38: 314-320.
41. Boulton AJM, Gries FA, Jervell JA,. Guidelines for the diagnosis and outpatient management of diabetic periperal neuropathy. Diabetic Medicine 1998: 15: 508-514.
42. Anfreasen CH, Morgensen MS, Borch-Johnsen K, Sandbaek A, Lauritzen T, Almind K, Hansen L, Jorgensen T, Pedersen O, Hanson D,. Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity, and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits. BMC Med Genet 2008; 9: 118-126.
43. Hu C, Wang C, Zhang R, Ng MC, Bao Y, Wang C, So WY, Ma RC, Ma X, Chan JC, Xiang K, Jia W,. Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese population. Diabetologia 2010; 53: 290-298.